Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Sylvia McBrinn
AddedMar 31, 2024
UpdatedMay 1, 2026
Sylvia McBrinn

Sylvia McBrinn

Board Member, Axerion Therapeutics

Sylvia McBrinn's Career

Axerion Therapeutics
Axerion Therapeutics

Branford, CT, US

Board Member· Board
ReNetX Bio
ReNetX Bio

New Haven, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Sylvia McBrinn's Career

Axerion Therapeutics
Axerion Therapeutics
Angel$1.1M342009Branford, CT, US
Board Member· Board

Leadership at Axerion Therapeutics

David WurzerDavid WurzerBoard Member

Similar to Axerion Therapeutics

Axonis TherapeuticsAxonis TherapeuticsCambridge, MA, USDrug Discovery, Therapeuticsest. 2008Axonis TherapeuticsCambridge, MA, US · est. 2008

AXONIS Therapeutics pioneers breakthrough therapies for incurable neurological disorders.

Angel · $14.5M38
Axonia MedicalAxonia MedicalKalamazoo, MI, USMedical Researchest. 2011Axonia MedicalKalamazoo, MI, US · est. 2011

Axonia Medical Inc. pioneers in biomedical research, developing technology for neural restoration using tissue-engineered grafts.

Seed · $5M6
Axsome TherapeuticsAxsome TherapeuticsNew York City, NY, USTherapeuticsest. 2012Axsome TherapeuticsNew York City, NY, US · est. 2012

American biopharmaceutical firm, Axsome Therapeutics, develops therapies for pain and neurological disorders globally.

Public · $432M383
Axial TherapeuticsAxial TherapeuticsWoburn, MA, USTherapeuticsest. 2016Axial TherapeuticsWoburn, MA, US · est. 2016

Axial Biotherapeutics develops gut-restricted small molecules for treating central nervous system disorders.

Series C · $110.9M29
ReNetX Bio
ReNetX Bio
Seed$9.8M72009New Haven, CT, US
Board Member· Board

Leadership at ReNetX Bio

Steve StrittmatterSteve StrittmatterCo-Founder
David I ScheerDavid I ScheerBoard Member
Erika SmithErika SmithCo-Founder
George MaynardGeorge MaynardCo-Founder
MohsenMohsenBoard Member
Erika R SmithErika R SmithCEO

Similar to ReNetX Bio

NeuroCytonixNeuroCytonixRockville, MD, USMedical Treatmentsest. 2017NeuroCytonixRockville, MD, US · est. 2017

NeuroCytonix Inc: A pioneering biotech firm specializing in innovative nervous system regeneration technologies.

Series A · $4M25
Novoron BioscienceNovoron BioscienceSan Diego, CA, USPharmaceutical Therapiesest. 2014Novoron BioscienceSan Diego, CA, US · est. 2014

Biotech firm specializing in pharmaceutical therapies for central nervous system regeneration.

Seed · $13.8M5
RegennovaRegennovaDurham, NC, USMedical Solutionsest. 2022RegennovaDurham, NC, US · est. 2022

Regennova: A biotech firm innovating medical solutions for neurological disorders and inflammatory illnesses.

Angel · $5k5
Revive BiotechnologyRevive BiotechnologyChampaign, IL, USNanotechnology, Therapeuticsest. 2018Revive BiotechnologyChampaign, IL, US · est. 2018

Revive Biotech: Innovating nanotech solutions for ocular health, focusing on retinal artery occlusion.

Angel · $256k2

People Similar to Sylvia McBrinn

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoSara ZaknoenSara ZaknoenBoard Member · aTyr PharmaGina LoftenGina LoftenBoard Member · TiaaElliot L SheltonElliot L SheltonBoard Member · Total Nutraceutical Solutionswilliam poolewilliam pooleBoard Member · Accentia BiopharmaceuticalsMatthew BruffMatthew BruffBoard Member · AltelaCyrille Y N PetitCyrille Y N PetitBoard Member · Bioventus